Sign In
Buy SGMT
Sagimet Biosciences Stock Insider Power
Based on the 100 latest insides trades, we have calculated the insider power to be negative at -18.03. In total, the insiders bought 6.44M and sold 433.79K SGMT shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.
Insider Power
|
-18.03 |
| ● Buy | 6.44M shares |
| ● Sell | 433.79K shares |
|
78% Buy Activity
Moderate Negative Correlation
|
|
Historical Insider Trades
| Date | Type | Person | Role | Amount |
|---|---|---|---|---|
|
Jul 20, 2026 Sell |
Happel David President & CEO |
64 051 Value: $497.1K |
||
|
Jul 20, 2026 Sell |
Rozek Elizabeth Chief Legal & Admin. Officer |
10 545 Value: $81.8K |
||
|
Jul 20, 2026 Sell |
Kemble George Director |
18 844 Value: $140.5K |
||
|
Jun 12, 2026 Buy |
Seidenberg Beth C Director |
39 567 Value: $256.4K |
||
|
Jun 12, 2026 Buy |
Hoelscher Paul W. Director |
39 567 Value: $256.4K |
||
|
Jun 12, 2026 Buy |
Jarrett Jennifer Director |
39 567 Value: $256.4K |
||
|
Jun 12, 2026 Buy |
Grammer Elizabeth A Director |
39 567 Value: $256.4K |
||
|
Jun 12, 2026 Buy |
Kemble George Director |
39 567 Value: $256.4K |
||
|
Jun 12, 2026 Buy |
Phillips Anne M. Director |
39 567 Value: $256.4K |
||
|
May 28, 2026 Buy |
Chauche Thierry Chief Financial Officer |
50 000 Value: $363.5K |
||
|
May 28, 2026 Buy |
Grauer Andreas Chief Medical Officer |
35 000 Value: $254.5K |
||
|
May 28, 2026 Buy |
Rozek Elizabeth Chief Legal & Admin. Officer |
100 000 Value: $727.0K |
||
|
May 28, 2026 Buy |
Happel David President & CEO |
300 000 Value: $2.18M |
||
|
Apr 20, 2026 Buy |
Grauer Andreas Chief Medical Officer |
264 759 Value: $1.71M |
||
|
Apr 20, 2026 Buy |
Grauer Andreas Officer |
0 Value: $0 |
||
|
Feb 19, 2026 Buy |
Rozek Elizabeth Chief Legal & Admin. Officer |
44 000 Value: $236.7K |
||
|
Feb 19, 2026 Buy |
Rozek Elizabeth Chief Legal & Admin. Officer |
88 000 Value: $473.4K |
||
|
Feb 19, 2026 Buy |
Martins Eduardo Bruno Chief Medical Officer |
44 000 Value: $236.7K |
||
|
Feb 19, 2026 Buy |
Martins Eduardo Bruno Chief Medical Officer |
88 000 Value: $473.4K |
||
|
Feb 19, 2026 Buy |
Happel David President & CEO |
128 000 Value: $688.6K |
||
|
Feb 19, 2026 Buy |
Happel David President & CEO |
256 000 Value: $1.38M |
||
|
Feb 19, 2026 Buy |
Chauche Thierry Chief Financial Officer |
88 000 Value: $473.4K |
||
|
Feb 19, 2026 Buy |
Chauche Thierry Chief Financial Officer |
44 000 Value: $236.7K |
||
|
Feb 10, 2026 Sell |
Happel David President & CEO |
12 101 Value: $64.9K |
||
|
Feb 10, 2026 Sell |
Chauche Thierry Chief Financial Officer |
1 312 Value: $7K |
About Insider Power
Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.
It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.
While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.
* October 6th, 2025 - Tested on 5562 stocks
